These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference. Dmochowski RR; Newman DK; Sand PK; Rudy DC; Caramelli KE; Thomas H; Hoel G Clin Drug Investig; 2011; 31(8):559-571. PubMed ID: 21721591 [TBL] [Abstract][Full Text] [Related]
14. Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder. Staskin DR; Robinson D Expert Opin Pharmacother; 2009 Dec; 10(18):3103-11. PubMed ID: 19954278 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects. Appell RA; Chancellor MB; Zobrist RH; Thomas H; Sanders SW Mayo Clin Proc; 2003 Jun; 78(6):696-702. PubMed ID: 12934778 [TBL] [Abstract][Full Text] [Related]
16. A phase 2, randomized, double-blind, efficacy and safety study of oxybutynin vaginal ring for alleviation of overactive bladder symptoms in women. Gittelman M; Weiss H; Seidman L J Urol; 2014 Apr; 191(4):1014-21. PubMed ID: 24231837 [TBL] [Abstract][Full Text] [Related]
17. Which anticholinergic drug for overactive bladder symptoms in adults. Hay-Smith J; Herbison P; Ellis G; Morris A Cochrane Database Syst Rev; 2005 Jul; (3):CD005429. PubMed ID: 16034974 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder. Anderson RU; MacDiarmid S; Kell S; Barada JH; Serels S; Goldberg RP Int Urogynecol J Pelvic Floor Dysfunct; 2006 Sep; 17(5):502-11. PubMed ID: 16724169 [TBL] [Abstract][Full Text] [Related]
19. Comparison of electric stimulation and oxybutynin chloride in management of overactive bladder with special reference to urinary urgency: a randomized placebo-controlled trial. Wang AC; Chih SY; Chen MC Urology; 2006 Nov; 68(5):999-1004. PubMed ID: 17113893 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]